Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recombinant Proteins: Understanding 5 Key Process Development Challenges | Contract Pharma

What are you searching for?

Sign in
White Papers / Tech Papers

Recombinant Proteins: Understanding 5 Key Process Development Challenges

It is important to ensure process elements like scalability, sourcing raw materials, and GMP adherence are considered during process development.

For many biotech companies, particularly those developing orphan or small-market drugs, process development is not the first thing on their mind. While they understand the importance of creating a scalable and repeatable process resistant to supply chain disruptions, the need to conceive a viable molecule takes precedence in early development.

Once a company has demonstrated proof of concept, it is important to ensure process elements like scalability, sourcing raw materials, and GMP adherence are considered during process development.

Every project is different, and some elements may not have even been considered, while others may have been partially implemented but not optimized. The company must use this baseline in determining which process elements it can handle internally and which elements might, or will, require outsourced assistance.

DOWNLOAD CONTENT USING THE FORM TO READ MORE >>>>>

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics